Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherie A Dowsett

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
American Heart Journal|May 8, 2004
Cardiovascular effects of raloxifene: the arterial and venous systemsRoger S Blumenthal, Bryan Baranowski, Sherie A Dowsett
Journal of Periodontology|September 26, 2002
The applicability of half-mouth examination to periodontal disease assessment in untreated adult populationsSherie A Dowsett, George J Eckert, Michael J Kowolik
International Journal of Medical Sciences|March 9, 2013
Duloxetine and pregnancy outcomes: safety surveillance findingsSharon L Hoog, Yingkai Cheng, John Elpers, et al.
Current Medical Research and Opinion|March 31, 2010
Developing good scientific publishing practices: one pharmaceutical company's perspectiveSherie A Dowsett, Luann E Van Campen, Lisa A Bednar
Clinical Therapeutics|July 21, 2004
Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of actionMichael B Sporn, Sherie A Dowsett, John Mershon, et al.
Cleveland Clinic Journal of Medicine|April 14, 2005
The impact of stress urinary incontinence on sexual activity in womenMatthew D Barber, Sherie A Dowsett, Karen J Mullen, et al.
Menopause (New York, N.Y.)|July 23, 2005
Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics, and effect of raloxifeneClaire S Duvernoy, Pandurang M Kulkarni, Sherie A Dowsett, et al.
Current Medical Research and Opinion|October 4, 2005
Safety assessment of raloxifene over eight years in a clinical trial settingSilvana Martino, Damon Disch, Sherie A Dowsett, et al.
Current Medical Research and Opinion|July 2, 2014
Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findingsDavid B Henley, Karen L Sundell, Gopalan Sethuraman, et al.
Breast Cancer Research and Treatment|October 10, 2006
Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factorsJane A Cauley, Jingli Song, Sherie A Dowsett, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
American Heart Journal|May 8, 2004
Cardiovascular effects of raloxifene: the arterial and venous systemsRoger S Blumenthal, Bryan Baranowski, Sherie A Dowsett
Journal of Periodontology|September 26, 2002
The applicability of half-mouth examination to periodontal disease assessment in untreated adult populationsSherie A Dowsett, George J Eckert, Michael J Kowolik
International Journal of Medical Sciences|March 9, 2013
Duloxetine and pregnancy outcomes: safety surveillance findingsSharon L Hoog, Yingkai Cheng, John Elpers, et al.
Current Medical Research and Opinion|March 31, 2010
Developing good scientific publishing practices: one pharmaceutical company's perspectiveSherie A Dowsett, Luann E Van Campen, Lisa A Bednar
Clinical Therapeutics|July 21, 2004
Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of actionMichael B Sporn, Sherie A Dowsett, John Mershon, et al.
Cleveland Clinic Journal of Medicine|April 14, 2005
The impact of stress urinary incontinence on sexual activity in womenMatthew D Barber, Sherie A Dowsett, Karen J Mullen, et al.
Menopause (New York, N.Y.)|July 23, 2005
Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics, and effect of raloxifeneClaire S Duvernoy, Pandurang M Kulkarni, Sherie A Dowsett, et al.
Current Medical Research and Opinion|October 4, 2005
Safety assessment of raloxifene over eight years in a clinical trial settingSilvana Martino, Damon Disch, Sherie A Dowsett, et al.
Current Medical Research and Opinion|July 2, 2014
Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findingsDavid B Henley, Karen L Sundell, Gopalan Sethuraman, et al.
Breast Cancer Research and Treatment|October 10, 2006
Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factorsJane A Cauley, Jingli Song, Sherie A Dowsett, et al.
Pageof 5